Gut Microbiota Influences on Colorectal Cancer Dynamics

The human gut microbiota exerts a profound influence on colorectal cancer dynamics, shaping tumour initiation, progression and response to therapy. A state of microbial imbalance, or dysbiosis, can permit expansion of pro-carcinogenic species that produce genotoxins, provoke chronic inflammation or disrupt host epigenetic landscapes. Conversely, beneficial commensals generate short-chain fatty acids such as butyrate that maintain mucosal integrity and restrain tumour growth. Distinct microbial consortia colonise mucosal surfaces at different stages of colorectal tumourigenesis, with early adenomas marked by subtle shifts in community structure and advanced carcinomas exhibiting invasive biofilms dominated by oral pathobionts. Host–microbe interactions modulate immune surveillance, epithelial barrier function and metabolic signalling, creating a dynamic microenvironment that favours malignant transformation. Translational studies are harnessing microbial signatures to develop non-invasive screening tools and to design microbiota-targeted interventions, including dietary modulation, probiotics and bacteriophage therapy. Global variations in diet, lifestyle and genetics further influence microbiota composition, underscoring the need for personalised approaches. Understanding the complex interplay between microbial ecology and colorectal carcinogenesis offers new avenues for prevention, early detection and adjunctive treatment strategies.

Research from Nature Portfolio

Recent work has dissected the gut mucosal microbiome across discrete stages of colorectal tumourigenesis. Analysis of paired samples from adenoma, carcinoma and adjacent non-neoplastic mucosa reveals an emerging metacommunity enriched in oral bacterial taxa at the adenoma stage, progressing to a distinct consortium in carcinoma. Early dysbiosis is characterised by shifts in community configuration, while advanced lesions exhibit co-exclusive bacterial relationships and invasive biofilm structures, particularly in proximal tumours. These findings have been validated across multiple cohorts, implicating a taxonomically defined microbial consortium in driving colorectal cancer progression.

Gut Microbiota Influences on Colorectal Cancer Dynamics publication trend

The graph below shows the total number of articles in gut microbiota influences on colorectal cancer dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Dysbiosis: An imbalance in the structure or function of a microbial community that can promote disease.

Pathobiont: A normally commensal microbe with the potential to cause pathology under certain conditions.

Metacommunity: A network of interacting microbial communities occupying linked habitats or niches.

Biofilm: A structured microbial community adherent to surfaces and embedded in an extracellular matrix.

Epigenetic modifications: Heritable changes in gene expression not involving alterations in DNA sequence, such as DNA methylation.

Short-chain fatty acids: Microbial fermentation products (e.g., acetate, propionate, butyrate) that modulate host cell functions.

Adenoma: A benign epithelial neoplasm that can progress to carcinoma.

References

1. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nature Communications (2015).
2. Parvimonas micra, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes. Gut Microbes (2023).
3. The Intestinal Microbiota and Colorectal Cancer. Frontiers in Immunology (2020).
4. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Medicine (2016).